TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Regencell Bioscience ( (RGC) ) has provided an update.
On June 30, 2025, Regencell Bioscience Holdings Limited announced the appointment of Ms. Margaret Hoor Han Lo as an independent director, following the resignation of Mr. Paul J. Niewiadomski. Ms. Lo brings over 30 years of experience in real estate investments and will serve on several key committees. Mr. Niewiadomski resigned for personal reasons and will continue in an advisory role, with no disagreements cited with the company.
More about Regencell Bioscience
Regencell Bioscience Holdings Limited operates within the bioscience industry, focusing on innovative healthcare solutions. The company is incorporated under the laws of the Cayman Islands and is based in Hong Kong.
Average Trading Volume: 3,304,204
Technical Sentiment Signal: Buy
Current Market Cap: $8.6B
Find detailed analytics on RGC stock on TipRanks’ Stock Analysis page.